232 related articles for article (PubMed ID: 24021961)
1. Antimicrobial peptide LL-37 and IDR-1 ameliorate MRSA pneumonia in vivo.
Hou M; Zhang N; Yang J; Meng X; Yang R; Li J; Sun T
Cell Physiol Biochem; 2013; 32(3):614-23. PubMed ID: 24021961
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial peptide LL-37 attenuates LTA induced inflammatory effect in macrophages.
Ruan Y; Shen T; Wang Y; Hou M; Li J; Sun T
Int Immunopharmacol; 2013 Mar; 15(3):575-80. PubMed ID: 23375934
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37.
Krasnodembskaya A; Song Y; Fang X; Gupta N; Serikov V; Lee JW; Matthay MA
Stem Cells; 2010 Dec; 28(12):2229-38. PubMed ID: 20945332
[TBL] [Abstract][Full Text] [Related]
4. Innate defense regulator peptide 1018 in wound healing and wound infection.
Steinstraesser L; Hirsch T; Schulte M; Kueckelhaus M; Jacobsen F; Mersch EA; Stricker I; Afacan N; Jenssen H; Hancock RE; Kindrachuk J
PLoS One; 2012; 7(8):e39373. PubMed ID: 22879874
[TBL] [Abstract][Full Text] [Related]
5. Intracellular receptor for human host defense peptide LL-37 in monocytes.
Mookherjee N; Lippert DN; Hamill P; Falsafi R; Nijnik A; Kindrachuk J; Pistolic J; Gardy J; Miri P; Naseer M; Foster LJ; Hancock RE
J Immunol; 2009 Aug; 183(4):2688-96. PubMed ID: 19605696
[TBL] [Abstract][Full Text] [Related]
6. IL-9 blockade attenuates inflammation in a murine model of methicillin-resistant Staphylococcus aureus pneumonia.
Xu W; Tian K; Li X; Zhang S
Acta Biochim Biophys Sin (Shanghai); 2020 Feb; 52(2):133-140. PubMed ID: 31942919
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory innate defence regulator (IDR) peptide alleviates airway inflammation and hyper-responsiveness.
Piyadasa H; Hemshekhar M; Altieri A; Basu S; van der Does AM; Halayko AJ; Hiemstra PS; Mookherjee N
Thorax; 2018 Oct; 73(10):908-917. PubMed ID: 29853649
[TBL] [Abstract][Full Text] [Related]
8. LL-37 restored glucocorticoid sensitivity impaired by virus dsRNA in lung.
Li K; Tao N; Zheng L; Sun T
Int Immunopharmacol; 2020 Feb; 79():106057. PubMed ID: 31877496
[TBL] [Abstract][Full Text] [Related]
9. Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury.
Bei Y; Pan LL; Zhou Q; Zhao C; Xie Y; Wu C; Meng X; Gu H; Xu J; Zhou L; Sluijter JPG; Das S; Agerberth B; Sun J; Xiao J
BMC Med; 2019 Feb; 17(1):42. PubMed ID: 30782145
[TBL] [Abstract][Full Text] [Related]
10. Bacterial pneumonia-induced shedding of epithelial heparan sulfate inhibits the bactericidal activity of cathelicidin in a murine model.
Zehr EP; Erzen CL; Oshima K; Langouet-Astrie CJ; LaRiviere WB; Shi D; Zhang F; McCollister BD; Windham SL; Rizzo AN; Bastarache JA; Horswill AR; Schmidt EP; Kwiecinski JM; Colbert JF
Am J Physiol Lung Cell Mol Physiol; 2024 Feb; 326(2):L206-L212. PubMed ID: 38113313
[TBL] [Abstract][Full Text] [Related]
11. LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents.
Haisma EM; de Breij A; Chan H; van Dissel JT; Drijfhout JW; Hiemstra PS; El Ghalbzouri A; Nibbering PH
Antimicrob Agents Chemother; 2014 Aug; 58(8):4411-9. PubMed ID: 24841266
[TBL] [Abstract][Full Text] [Related]
12. Modulation of antimicrobial potency of human cathelicidin peptides against the ESKAPE pathogens and in vivo efficacy in a murine catheter-associated biofilm model.
Narayana JL; Mishra B; Lushnikova T; Golla RM; Wang G
Biochim Biophys Acta Biomembr; 2019 Sep; 1861(9):1592-1602. PubMed ID: 31319057
[TBL] [Abstract][Full Text] [Related]
13. Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment.
Nijnik A; Madera L; Ma S; Waldbrook M; Elliott MR; Easton DM; Mayer ML; Mullaly SC; Kindrachuk J; Jenssen H; Hancock RE
J Immunol; 2010 Mar; 184(5):2539-50. PubMed ID: 20107187
[TBL] [Abstract][Full Text] [Related]
14. LL-37-derived membrane-active FK-13 analogs possessing cell selectivity, anti-biofilm activity and synergy with chloramphenicol and anti-inflammatory activity.
Rajasekaran G; Kim EY; Shin SY
Biochim Biophys Acta Biomembr; 2017 May; 1859(5):722-733. PubMed ID: 28161291
[TBL] [Abstract][Full Text] [Related]
15. Human cathelicidin LL-37-derived peptide IG-19 confers protection in a murine model of collagen-induced arthritis.
Chow LN; Choi KY; Piyadasa H; Bossert M; Uzonna J; Klonisch T; Mookherjee N
Mol Immunol; 2014 Feb; 57(2):86-92. PubMed ID: 24091294
[TBL] [Abstract][Full Text] [Related]
16. Immune regulatory activities of fowlicidin-1, a cathelicidin host defense peptide.
Bommineni YR; Pham GH; Sunkara LT; Achanta M; Zhang G
Mol Immunol; 2014 May; 59(1):55-63. PubMed ID: 24491488
[TBL] [Abstract][Full Text] [Related]
17. The antimicrobial potential of a new derivative of cathelicidin from Bungarus fasciatus against methicillin-resistant Staphylococcus aureus.
Tajbakhsh M; Karimi A; Tohidpour A; Abbasi N; Fallah F; Akhavan MM
J Microbiol; 2018 Feb; 56(2):128-137. PubMed ID: 29392557
[TBL] [Abstract][Full Text] [Related]
18. Cathelicidin LL-37 restoring glucocorticoid function in smoking and lipopolysaccharide-induced airway inflammation in rats.
Weng JZ; Wang Y; Sun TY
Chin Med J (Engl); 2019 Mar; 132(5):569-576. PubMed ID: 30741829
[TBL] [Abstract][Full Text] [Related]
19. Tenascin C Has a Modest Protective Effect on Acute Lung Pathology during Methicillin-Resistant Staphylococcus aureus-Induced Pneumonia in Mice.
Meijer MT; de Vos AF; Peters Sengers H; Scicluna BP; Roelofs JJ; Abou Fayçal C; Uhel F; Orend G; van der Poll T
Microbiol Spectr; 2021 Sep; 9(1):e0020721. PubMed ID: 34319124
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Host Responses during Pseudomonas aeruginosa Acute Infection in the Lungs and Blood and after Treatment with the Synthetic Immunomodulatory Peptide IDR-1002.
Wuerth K; Lee AHY; Falsafi R; Gill EE; Hancock REW
Infect Immun; 2019 Jan; 87(1):. PubMed ID: 30323028
[No Abstract] [Full Text] [Related]
[Next] [New Search]
